Objective: The aim of this study was to analyze the rates, reasons, and risk factors of 30-day readmission, both planned and unplanned, after carotid revascularization as well as to evaluate major outcomes associated with those readmissions.
With the continuous improvement of revascularization techniques, we sought to evaluate 30-day readmission, including causes and risk factors, after CEA and CAS using a large nationwide database. This can offer insight into clinical decision-making and can guide effective strategies that can reduce readmission and improve the quality of care of patients undergoing carotid revascularization.
METHODS
Data source. A retrospective study using the Premier Healthcare database (PHD) between 2009 and 2015 was performed and approved by the Institutional Review Board. The PHD is a large, U.S. hospital-based, servicelevel, all-payer database that contains information on inpatient discharges, primarily from geographically diverse nonprofit, nongovernmental, community and teaching hospitals and health systems from rural and urban areas. The PHD is a dynamic database that is updated weekly. To date, the PHD maintains cumulative information from >700 hospitals with >80 million inpatient admissions since 2011 (approximately 20% of annual inpatient discharges in the United States). 17 The PHD offers deidentified, Health Insurance Portability and Accountability Act-compliant data from standard hospital discharge billing files. These data include demographics and disease states; admission and discharge diagnoses; information on billed services, including costs and charges at the departmental level; and patient disposition and discharge health status. For most data elements, <1% of patient records have missing information; and for key elements, such as demographics and diagnostic information, <0.01% have missing data. Data are subject to an extensive validation process occurring during implementation and with each monthly data submission by the hospital to ensure accurate and complete reporting.
Subjects.
Patients who underwent carotid revascularization (CAS or CEA) were identified using admission and primary procedure-specific codes from the International Classification of Diseases, Ninth Revision, Clinical Modification for CAS (00.63) and CEA (38.12) . Patients with concomitant contralateral or ipsilateral carotid revascularization (0.12%), length of stay >30 days (0.35%), and death during the index hospital stay (0.6%) were excluded from the analysis. The need for informed consent of the patients was waived because the data are deidentified data and not considered human subjects research under federal guidelines.
Outcomes. The primary outcome of interest was 30-day readmission. Using a unique masked identifier, patients were tracked across the inpatient settings to assess consecutive admissions to the index hospital in a chronologic order as well as the cumulative number of days since the previous admission. Secondary outcomes included medical and surgical complications during both the initial hospitalization and the readmission stay. These were identified using secondary diagnosis and procedure codes provided in Supplementary Table I (online only). Device-related complications included stent occlusion, CEA patch infection, and occlusion of the carotid artery. Furthermore, in-hospital outcomes in readmitted patients including mortality, complications, and total hospitalization costs were analyzed. Costs are those reported by the hospital. They are not the charge to a payer or the amount reimbursed to the hospital. Currency data were presented as medians, adjusted for inflation for 2015 U.S. dollars using the Consumer Price Index Inflation Calculator from the U.S. Department of Labor. Symptomatic status was defined as presenting with transient cerebral ischemia, carotid artery stenosis with cerebral infarction, stroke, or transient limb paralysis as well as retinal vascular occlusion or retinal ischemia.
Statistical analyses. Student independent t-tests and Wilcoxon rank sum tests were used to analyze continuous variables, and c 2 tests were used to compare categorical variables. Multiple logistic regression models were used to study the association between 30-day readmission and patients' demographics, comorbidities, symptomatic status, and discharge destination as well as hospital teaching status and provider regions. Variables included in the final models were chosen on the basis of clinical relevance or a P value # .20 on initial bivariate analysis. C statistics and the Hosmer-Lemeshow test evaluated the models' predictive ability and goodness of fit, respectively. Regression models were also checked for multicollinearity using variance inflation factors for each covariate (mean variance inflation factor, 1.13; maximum, 1.56). The analysis was validated using coarsened exact matching (CEM) described by Iacus et al 18 
RESULTS
A total of 95,687 patients underwent carotid revascularization between 2009 and 2015: 82,817 CEA (86.5%) and 12,870 (13.5%) CAS. Of those, 6118 (6.4%) were readmitted within 30 days of discharge (CEA, 6.5%; CAS, 6.1%; P ¼ .10).
Comparison of baseline characteristics between the two groups is shown in Table I . Occurrence of more than one readmission was more common after CAS than after CEA (31% vs 25%; P < .001). Compared with patients not readmitted within 30 days, those readmitted were older (73 6 8.6 years vs 71.8 6 8.3 years; P < .001), were more often women (43.4% vs 41.2%; P < .001) and African Americans (5.6% vs 4.1%; P < .001), and were mostly covered by Medicare (81.7% vs 78.1%; P < .001; Table II) . Moreover, they were more likely to be readmitted after emergency or urgent index procedures (36.2% vs 19.9%; P < .001) or with concomitant cardiac procedures (34.2% vs 22.8%; P < .001).
Readmitted patients were more likely to be symptomatic on initial presentation (21.4% vs 13.1%; P < .001) and had a higher prevalence of comorbid conditions, such as diabetes (40.9% vs 34.2%), history of MI (15.5% vs 12.7%), . A significant portion of readmitted patients were not discharged home initially, with 10.5% transferred to a general hospital or a skilled nursing facility and 11.3% discharged home under a home health service organization.
Causes of readmission. A total of 7153 readmissions occurred, mostly 1 week after discharge from the hospital. Other than nonspecific complaints such as fatigue, fever, headache, syncope, and admission for physical therapy, most common indications of these readmissions (n ¼ 7153) were related to cardiac, neurologic, infectious, and respiratory complications (Fig) . Stroke was one of the most common reasons for readmission after both CAS and CEA (8.3% vs 6.7%; P ¼ .07), followed by hemorrhage/shock/bleeding (5.3% vs 6.9%; P ¼ .06), pneumonia (2.4 vs 3.4%; P ¼ .12), and respiratory failure (3.9% vs 4.4%; P ¼ .5). MI and wound complications were more likely to be an indication for readmission after CEA compared with CAS (4.1% vs 2.5% [P ¼ .02] and 4.1% vs 1.5% [P < .001], respectively; Table III ). On the other hand, readmissions due to vascular or stent-related complications were more likely after CAS than after CEA (5.8% vs 3.8%; P ¼ .003).
Predictors of 30-day readmission. After multivariate adjustment, CEA was found to be associated with 41% higher odds of readmission compared with CAS (adjusted odds ratio [ Table IV ).
Subgroup analysis: CEM. Exact one-to-one matching was performed on the basis of baseline characteristics that were shown to be significantly different between CEA and CAS patients, including age, gender, race, insurance coverage, admission type, presence of concomitant cardiac procedures, region (urban vs rural), provider area, hospital teaching status, and medical comorbidities that make up the Charlson Comorbidity Index (history of MI, CHF, connective tissue disease, paraplegia/hemiplegia, peripheral arterial disease, and renal disease). This yielded two comparison groups each with 8966 patients (Supplementary Table II , online only). Comparison of the two groups showed higher adjusted 30-day readmission rates after CEA compared with CAS (6.2% vs 4.9%; P < .001). Secondary outcomes that are significantly different between CEA and CAS were in-hospital stroke (1.8% vs 1.2%; P < .01), arrhythmia (4.9% vs 6.7%; P < .001), hemorrhage/bleeding (8.6% vs 7.4%; P < .01), acute kidney injury (1.8% vs 1.5%; P ¼ .05), and discharge disposition (Table V) . We further controlled for in-hospital postoperative complications, and readmission was still 35% higher after CEA compared with CAS (aOR, 1.35; 95% CI, 1.18-1.54; P < .001).
Outcomes of readmitted patients. Patients readmitted after CAS had a longer length of hospital stay (5 days vs 4 days; P ¼ .001) and significantly higher readmission mortality (6.2% vs 2.8%; P < .001) compared with those readmitted after CEA. Adjusted readmission mortality was two times higher in patients readmitted after CAS vs CEA (aOR, 2.0; 95% CI, 1.5-2.8; P < .001). Throughout the readmission, patients were also subject to various adverse events complicating the course of their rehospitalization after CEA and CAS. These included bleeding (4.8% after CEA vs 3.1% after CAS; P ¼ .02), cardiac (6.7% vs 6.1%; P ¼ .53), respiratory (3.5% vs 5.0%; P ¼ .03), and renal (5.3% vs 6.7%; P ¼ .10) complications. The median total, fixed, and variable costs of readmission were higher if the readmission occurred after CAS compared with CEA ($8903, $4313, and $4390 vs $7629, $3762, and $3651, respectively). Adjusted rehospitalization costs after CAS were higher by around U.S. $700 compared with those after CEA (Table VI) .
DISCUSSION
Carotid revascularization is a high-volume procedure with significant readmission rates. The likelihood that the Centers for Medicare and Medicaid Services will penalize readmissions after vascular procedures in the future is high; thus, reducing unplanned readmissions has become of prominent importance to improve quality of care and to reduce significant expenses both to the health care system and to the patient. 19 The overall 30-day readmission rate in our study was around 6.4%, which is comparable to that reported using other large population databases. [20] [21] [22] Al-Damluji et al 1 reported a much higher unadjusted 30-day readmission rate (9.6%). For CEA, overall reported readmission rates are around 6.5% 15, 20, 22, 23 but can be as high as 9.4%. 24 On the other hand, reported readmission rates after CAS range between 9.7% 22 and 11.11%, 25 which is higher compared with our study (6.1%).
Our study shows an association between CEA and increased all-cause readmission rates after risk adjustment (aOR, 1.41; 95% CI, 1.29-1.54; P < .001) as well as after exact matching (6.2% vs 4.9%; P < .001). This is in contrast to two previous studies that demonstrated higher adjusted risk of readmission after CAS compared with CEA.
1, 25 Galinanes et al 25 race. An important finding by the authors was that the variation in proportional use of CAS was not associated with differences in hospital risk-standardized readmission rates. Thus, hospitals with more frequent CAS use will not necessarily be disadvantaged when hospitals with higher than expected readmissions are penalized. However, an editorial comment on that study cautioned that the poorer performance of CAS might be due to selection bias, which could not be adjusted for, and that the small difference in readmission rates between the two procedures might not be meaningful as it could be a potential artifact of the study's large sample size. 26 The lower readmission rates after CAS in our study might be explained by several factors, such as the use of different databases and different time frames as well as the continuous decline in 30-day major adverse events after CAS due to the refinement in CAS techniques, development of better stents and protection devices, better selection of patients for each procedure, and increased expertise of operators over time. Unlike the cited studies that examined Medicare data between The most common indications of readmission in our cohort were stroke, cardiac, infectious, and respiratory complications, which are more likely to develop in CEA patients after hospital discharge compared with the immediate complications of CAS. 20, 27, 28 In the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST), the majority of CAS strokes occurred on day 0 after the procedure, whereas CEA strokes were distributed evenly over 30 days postoperatively. This could explain increased readmission after CEA due to stroke despite lower overall stroke rates compared with CAS. 27 A recent study by our group using the American College of Surgeons National Surgical Quality Improvement Program database and another by Greenleaf et al using the Pennsylvania Health Care Cost Containment Council database showed that the risk of 30-day readmission was not procedure related but rather determined by symptomatic status and comorbidities. 22, 24 In our analyses, readmission remained significantly higher after CEA than after CAS even after adjusting for patients' comorbidities and symptomatic status. These findings add to the benefits and cost-effectiveness of the less invasive CAS in highrisk patients who are not candidates for surgery. However, the lower readmission rates of CAS are opposed by the high mortality associated with these readmissions. As evident in Table VI , patients readmitted after CAS have a longer hospital stay compared with patients readmitted after CEA (5 days vs 4 days; P ¼ .001), higher crude mortality (6.2% vs 2.8%; P < .001), and increased respiratory complications (5.0 vs 3.5%; P ¼ .03), reflecting a more difficult rehospitalization course in the high-risk CAS patients compared with CEA patients. This leads to significantly higher adjusted readmission costs for CAS patients by around $700 (Table VI) . Identifying preventable causes of readmission after carotid revascularization is a complex task, especially given that vascular surgery patients are usually older and have multiple comorbidities compared with patients in other surgical specialties. Readmission in this population of patients is thus highly related to their medical illnesses and comorbidities rather than to the index procedure. On the other hand, many readmissions in vascular surgery are planned. 25, 29 A significant portion of patients in our study were readmitted for nonspecific or nonrelated causes, such as cancer/chemotherapy, abdominal surgeries, and nonspecific complaints, such as fatigue, fever, headache, syncope, and physical therapy (Table III) . The key to reducing preventable readmissions is better perioperative planning and comorbidity management in high-risk patients. Older patients and those with major preoperative comorbidities (diabetes, renal disease, COPD, peripheral arterial disease, and cancer) are reported to have increased risk of adverse events leading to higher hospital readmissions. These may require a more intense preoperative maximization of the patient and close postoperative follow-up. 25, 30 Another prominent risk factor associated with increased readmission was nonhome discharge, mainly to skilled nursing facilities, rehabilitation centers, and hospice care. Among patients who were readmitted from those facilities, 16.8% had prior CAS compared with 11.2% who were readmitted from home (P < .001). Moreover, they had significant comorbidities, such as paraplegia/hemiplegia (21 (Table IV) . Despite the granularity of our clinical data, the model was able to predict only around 9% of the variability in 30-day readmission (R 2 ¼ 8.8; C statistic ¼ 69.5). Even after including in-hospital complications, the predictability did not significantly improve (R 2 ¼ 8.9; C statistic ¼ 69.6). This is not uncommon because the creation of models predicting preventable readmissions using inpatient hospital data and information present at discharge has been shown to be challenging in medical as well as in surgical patients, with C statistics similar to that reported in our study. 19, [31] [32] [33] [34] Moreover, readmissions in patients undergoing vascular surgery are mainly driven by postoperative complications that are identified after discharge. 34, 35 Al-Damluji et al 1 found that almost onethird of readmission diagnoses were potentially due to procedural complications. Similarly, Lawson et al 35 also
identified postoperative complications occurring after discharge as the single most predictive factor in surgical readmissions and a high-yield area for improvement of patient care. Readmission significantly constitutes a large burden to patients and health care systems. [36] [37] [38] Prior studies have suggested several interventions that focus on minimizing risk factors and addressing known and preventable reasons for readmission, such as wound infections, to improve health care quality and resource use. 26 Such interventions include improving outpatient management and transitional care, 39, 40 closer primary care follow-up after discharge, 41 and avoidance of premature discharge in high-risk patients to limit early and short readmissions. The majority of readmissions in our study occurred within the first week of discharge (median, 6 [interquartile range, 1-16] days), with some patients having more than one readmission within 30 days. This was also reported in other published studies. 1, 42 However, the success of isolated interventions has been questioned, especially that most have been studied in a retrospective manner. 43 Thus, prospective studies on overall cost-effectiveness of patient-centered bundled interventions are warranted. 19 Until then, it is reasonable to reconsider penalizing hospitals with high risk-standardized rates of readmissions.
Limitations. This retrospective analysis offers an overview of readmission after carotid revascularization using a large nationwide database, which can provide a platform for further investigations and targets for intervention. The multivariate analysis is further validated using CEM to ensure the validity and help reduce selection bias. However, risk adjustment and exact matching cannot control for all confounding variables or eliminate inherent selection bias of patients undergoing CAS vs those undergoing CEA. Furthermore, patients in both groups that could not be matched were discarded or pruned from the matched cohort. Thus, the matched cohort is likely not representative of the whole population of patients but rather provides risk-adjusted estimates of treatment effects. Another important limitation is that readmissions to a different hospital, other than the index hospital, are not tracked in the database, which might underestimate readmission rates. We cannot provide exact estimates on the number of readmissions to hospitals other than the index hospital, but this should not compromise the validity of our findings because our readmissions are limited to 30 days after discharge, in which most patients are readmitted usually to the index hospital where their vascular surgeon is available, especially if the readmissions are procedure related. In addition, administrative claims data may not be suitable for identifying staged or planned revascularization procedures. Planned or staged readmissions are significant in discussing peripheral revascularization procedures rather than carotid revascularizations.
CONCLUSIONS
In this study, overall 30-day readmission after carotid revascularization was 6.5%. After risk adjustment, CAS had lower readmission rates than CEA. However, the mortality and overall costs of readmissions were higher after CAS. Reducing readmissions requires identifying highrisk patients and managing their comorbidities and risk factors. Further prospective studies are needed to evaluate the cost-effectiveness of strategies aiming to reduce readmission rates after carotid revascularization.
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